Symbion Systems partners with Labtronics for LIMS solution

  • March 15, 2007
  • News
IRVINE, Calif., March 15, 2007 – Symbion and Labtronics will cooperate in offering integrated solutions combining the capabilities of Labtronics’ LimsLink with those of Symbion’s DX, RX, and LX product lines. The combination will provide customers with the advantages of LIMS integration and access to a spectroscopic data system capable of controlling virtually any spectrometer, while processing the large data arrays common to spectroscopy. The Symbion family of products is designed to provide a standard software environment for analytical instrumentation that is both a language and a set of comprehensive, yet easy to use programs, covering all aspects of analysis, connectivity, compliance, and control. Recognizing a range of customer needs for a robust solution to work in conjunction with the Symbion products, enabling LIMS connectivity for the various spectrometers and other analytical instruments, Symbion chose LimsLink, the most widely used and flexible instrument interfacing tool in the industry. With LimsLink, data can be easily collected and reported to LIMS, whether to acquire data from an instrument/instrument data system or to transfer information back and forth between the LIMS, the interface and the instrument. Through their expertise and robust solutions, Symbion and Labtronics will provide a powerful data management and interfacing solution. The combined solutions will improve laboratory workflow and assure compliance with industry regulations such as 21 CFR Part 11.About Symbion Systems, Inc.Symbion Systems, Inc. was founded in 2002 to develop and market standardized instrument control and data management software for the analytical instrument and process analysis industries. A major milestone in the Symbion program occurred during 2006 with the signing of a product licensing and joint development agreement with General Electric Fanuc Automation. Under the agreement, GE has acquired the primary marketing rights to the Life Sciences Process markets and the two companies have agreed to share in, and coordinate, all developments related to the Symbion product lines for at least five years. Symbion retains the primary rights to analytical laboratory markets and to process markets other than Life Sciences. Learn More

Did you enjoy this great article?

Check out our free e-newsletters to read more great articles..